Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02471846
What this trial is testing

GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Genentech, Inc. 158
Early research (Phase 1)Study completedNCT03238027
What this trial is testing

Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

Who this might be right for
Solid TumorMetastatic TumorLocally Advanced Malignant Neoplasm+1 more
Syndax Pharmaceuticals 45
Large-scale testing (Phase 3)Study completedNCT03115073
What this trial is testing

ProF-001_Phase IIa

Who this might be right for
Vulvovaginal Candidiasis (VVC)
ProFem GmbH 84
Testing effectiveness (Phase 2)Study completedNCT04721223
What this trial is testing

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorEsophageal Squamous Cell CarcinomaNon Small Cell Lung Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 12
Early research (Phase 1)Ended earlyNCT02439346
What this trial is testing

Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel

Who this might be right for
Medical Oncology
Bayer 15
Very early researchEnrolling By InvitationNCT06888661
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy (SMA)
Guangzhou Jiayin Biotech Ltd 4
Early research (Phase 1)Study completedNCT00932373
What this trial is testing

Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 54
Early research (Phase 1)Study completedNCT05249374
What this trial is testing

Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

Who this might be right for
Hepatic Ascites
Beijing Protgen Biotechnology Development Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT01284920
What this trial is testing

MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients

Who this might be right for
Prostate CancerProstate NeoplasmsCastration Resistant Prostate Cancer (CRPC)
Astellas Pharma Inc 47
Early research (Phase 1)Study completedNCT03401320
What this trial is testing

Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)

Who this might be right for
Healthy
Rovi Pharmaceuticals Laboratories 53
Early research (Phase 1)Looking for participantsNCT06590961
What this trial is testing

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
Ubix Therapeutics, Inc. 94
Early research (Phase 1)Study completedNCT01737424
What this trial is testing

Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

Who this might be right for
Healthy
LG Life Sciences 89
Early research (Phase 1)Ended earlyNCT02566759
What this trial is testing

A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants

Who this might be right for
Schizophrenia, Cerebellar Ataxia
Neurocrine Biosciences 110
Early research (Phase 1)Study completedNCT03033342
What this trial is testing

Single Dose and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4

Who this might be right for
Safety
MicuRx 122
Early research (Phase 1)Study completedNCT04169386
What this trial is testing

PCSK9 Inhibitor AK102 in Healthy Subjects

Who this might be right for
Hypercholesterolaemia
Akeso 32
Early research (Phase 1)Looking for participantsNCT07409922
What this trial is testing

Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants

Who this might be right for
Healthy
Jiangxi Kvvit Pharmaceutical Co., Ltd. 92
Early research (Phase 1)Study completedNCT02575651
What this trial is testing

A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Jiangsu HengRui Medicine Co., Ltd. 79
Early research (Phase 1)Study completedNCT06487845
What this trial is testing

Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Who this might be right for
Chronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers
Bayer 24
Early research (Phase 1)Study completedNCT02045472
What this trial is testing

VIS410 to Assess Safety and Pharmacokinetics

Who this might be right for
Influenza
Visterra, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT00036634
What this trial is testing

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

Who this might be right for
HIV Infections
Gilead Sciences 30
Next Page